N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl]-methyl ester L-valine monohydrochloride CAS NO.482577-59-3

Shijiazhuang Yiling Pharmaceutical Co.,ltd was founded in 1992 by professor Wu Yiling, who is one of prominent member of China Academy of Engineering, the company was successfully listed in Shenzhen Stock Exchange in 2011, worth over $6.25 billion. Yiling Group has multiple subsidiary around the world, with more than 16,000 employees. Now Yiling has developed into a great integrated pharmaceutical company, there are three business sectors: Modern Chinese medicine formulations, Chemical drugs and Healthcare products.

Wanyang Hengshui Pharmaceutical Co.,Ltd is the only API manufacturing factory of Yiling Group, located in high-tech industry development zone, Hengshu City, Hebei Province. Investment of $300 million, built into production in 2022, 280 employees, including 60 technical staff. The site has total area for phase I is 337122m². Wanyang will obtain the ISO9000、ISO14000、ISO18000 system certification, drug registration and GMP certificate in near future, then it will be a international modern factory in line with NMPA、EMA、FDA, etc... Factory bulit-up area is 120,000m², 4 workshops with 19 production lines (including multiple high activity production lines).

• NAME: N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl]-methyl ester L-valine monohydrochloride
• CAS: 482577-59-3
• Pure: 99%
•